GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biodexa Pharmaceuticals PLC (NAS:BDRX) » Definitions » Change In Other Working Capital

BDRX (Biodexa Pharmaceuticals) Change In Other Working Capital : $0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Biodexa Pharmaceuticals Change In Other Working Capital?

Biodexa Pharmaceuticals's Change In Other Working Capital for the quarter that ended in Dec. 2024 was $0.00 Mil. It means Biodexa Pharmaceuticals's Other Working Capital stayed the same from Jun. 2024 to Dec. 2024 .

Biodexa Pharmaceuticals's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was $0.00 Mil. It means Biodexa Pharmaceuticals's Other Working Capital increased by $0.00 Mil from Dec. 2023 to Dec. 2024 .

Biodexa Pharmaceuticals Change In Other Working Capital Historical Data

The historical data trend for Biodexa Pharmaceuticals's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biodexa Pharmaceuticals Change In Other Working Capital Chart

Biodexa Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.06 - 0.19 -0.26 -

Biodexa Pharmaceuticals Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 -0.26 - - -

Biodexa Pharmaceuticals Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biodexa Pharmaceuticals Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Biodexa Pharmaceuticals's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Biodexa Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biodexa Pharmaceuticals PLC (NAS:BDRX) » Definitions » Change In Other Working Capital
Comparable Companies
SIGY MBRX MBIO BZYR AZTR SNGX GLTO ICU AAGH SILO VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
1 Caspian Point, Caspian Way, Cardiff, GBR, CF10 4DQ
Website
https://www.biodexapharma.com
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.